Recently in this journal, Brunetti-Pierri et al. 1 published a report of seven patients with duplications at 14q12 that included the FOXG1 (MIM 164874). These patients presented with relatively severe neurodevelopmental phenotypes comprising intellectual disability, epilepsy and severe speech delay. Previously, we had reported a similarly affected patient with a deletion that also included FOXG1, 2 and more recently three patients with West syndrome were reported to have duplications that included FOXG1. 3, 4 FOXG1 encodes a brainspecific transcriptional repressor, 5 and deletions and point mutations in FOXG1 are known to cause the congenital variant of Rett syndrome, 6 making duplication of FOXG1 a strong candidate for the neurocognitive impairment in patient with 14q12 duplications.
In the course of a research project to identify genetic causes of hemifacial microsomia (MIM 164210), we identified a father-son pair who both have an interstitial duplication of B88 kb at 14q12 (chr14:28,236,716-28,325,210; UCSC genome browser, NCBI Build 36/hg18) ( Figure 1 ). The duplication was identified using an Illumina CytoSNP-12 microarray (Illumina Inc., San Diego, CA, USA) and independently confirmed using a synthetic multiplex ligation-dependent probe amplification assay 7 and/or Affymetrix 2.7M microarray (Affymetrix Inc., Santa Clara, CA, USA). The duplication contains only two genes, FOXG1 and C14orf23. Importantly, apart from hemifacial microsomia, the father and son are phenotypically normal, have normal intellect, do not have epilepsy, and have no family history of epilepsy or cognitive impairment.
It is difficult to reconcile the normal neurocognitive phenotype in this father and son pair with the relatively severe impairment reported in other patients with duplications that include FOXG1; however, several possible explanations must be considered. First, it remains possible that FOXG1 duplication is benign, and that the neurocognitive impairment reported in patients with 14q12 duplication is the result of duplication of other genes in the vicinity. Second, FOXG1 duplication may be incompletely penetrant, manifesting clinical abnormality only in the presence of other genetic or environmental factors. Third, in our father-son pair it is possible that of the three detected copies of FOXG1, only two are functional. Finally, FOXG1 may be subject to long-range regulatory elements, with gene transcription being differentially affected according to the location of the duplication breakpoints.
A duplication at 14q12 that encompasses FOXG1is also recorded in the Children's Hospital of Philadelphia CNV database, which comprises CNV data from 2026 healthy children aged 0-18. 8 This duplication is similar in size to the B3 Mb minimal duplicated region that includes FOXG1, c14orf32 and PRKD1 described in affected patients reported by Brunetti-Pierri et al. 1 Patients carrying these small-sized duplications (cases 1 and 5 in Figure 1) were assessed as non-dysmorphic, so it is possible the healthy CHOP patient is yet to present with developmental problems, infantile spasms or other seizures. Alternatively, this case provides further evidence that FOXG1 duplication may be benign or incompletely penetrant.
On the basis of these data, the role of duplication of FOXG1 in the pathogenesis of cognitive impairment and epilepsy remains uncertain. This case is a salient reminder that our understanding of the relationships between CNVs and phenotype is far from complete, and of the importance of reporting CNVs that are found in the presence of normal phenotypes. This is particularly important in the context of the increasing use of molecular karyotyping for prenatal diagnosis, where decision-making may be based on evidence of questionable validity. Microduplications on chromosome 14q11.2 including the FOXG1 gene have been reported in patients with developmental delay, cognitive impairment with speech delay, and epilepsy. 1-2 Such association has been confirmed subsequently in other patients. [3] [4] However, Amor et al 5 have found an B88 kb duplication at 14q12, encompassing the FOXG1 and C14orf23 genes in a father-son pair with isolated hemifacial microsomia. Neither the son nor the father exhibited mental retardation or epilepsy. They also identified an B3 Mb duplication of the 14q12 region, including FOXG1, in a child enrolled as a control subject in the CHOP CNV database 6 and questioned the pathogenicity of FOXG1 duplication.
Reply to Amor et al
We believe it is important to highlight that the clinical phenotypes observed in the seven patients in the original description of the syndrome include a relatively wide spectrum of neurodevelopmental abnormalities, ranging from mild to severe intellectual disability and variable presence of epilepsy (in four out of the seven patients). 1 Thus, it is not surprising that subjects at the mildest end of the spectrum may present with few or no clinically evident manifestations of the disease.
Moreover, the duplicated copy of FOXG1 reported by Amor et al 5 is small and may be devoid of its distant regulatory elements, which may explain the lack of neurocognitive phenotype. In support of this notion, two other FOX genes, FOXF1 and FOXL2, encoding for the evolutionarily conserved family of transcription factors with a central role in development have been shown recently to be upregulated by non-coding copy-number variants mapping over 250 kb 5¢ from these genes. [7] [8] Of note, FOXG1 expression is restricted to the brain, and thus more likely to be finely regulated by such distant enhancer(s) in a tissue-specific manner.
With regard to the individual in the CHOP CNV database with a FOXG1 duplication, we agree with the authors' suggestion that the CHOP subject with the duplication of FOXG1 may have not manifested yet the neurodevelopmental abnormalities.
On the basis of the well-established causative role of genomic deletions and point mutations of FOXG1 in determining a Rett-like phenotype 9-10 and the studies generated in animal models, 11 the evidence of FOXG1 as a dosage sensitive gene is compelling. Thus, we believe microduplications involving FOXG1 should not be considered of questionable pathogenicity but rather highly likely to be pathogenic, albeit associated with a wide spectrum of abnormal-
